
Pfenex
Pfenex develops biosimilar therapeutics and novel vaccines for the treatment and prevention of critical human health issues.
Employees
Enterprise value
$438m
Authorizing premium user...
Pfenex develops biosimilar therapeutics and novel vaccines for the treatment and prevention of critical human health issues.